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1. Introduction 
Our knowledge concerning the mechanism of 
hepatic triacylglycerol synthesis and secretion has 
made considerable progress over the last few years 
and general patterns of control are beginning to 
emerge [l]. Yet, very little is known about the break- 
down of hepatic triacylglycerols. Studies on the con- 
trol and the physiological role of hepatic lipolysis have 
been hampered by the fact that it was unknown which 
liver lipase was responsible for the hydrolysis of hepatic 
triacylglycerol stores (hepatic lipolysis). Throughout 
the text the terms lipolytic activity and lipase activity 
refer to triacylglycerol lipase activity (EC 3.1.1.3). 
Net lipolysis is defined as the decrease in triacylglycerol 
stores, measured either chemically or by the disap- 
pearance of radioactivity from triacylglycerols pre- 
labelled with radioactive fatty acids. Consequently, 
net lipolysis is the balance of triacylglycerol break- 
down (which is termed lipolysis per se) and triacyl- 
glycerol synthesis; in the case of prelabelled triacyl- 
glycerols the latter process means reesterification of 
labelled fatty acids. 
phospholipids [lo]. Monoacylglycerols produced 
from tri- or diacylglycerols are not processed further 
by the lysosomal lipase [7,10] but may be hydrolysed 
by a microsomal monoacylglycerol hydrolase [ 111. 
Lipolytic activities occurring in cytosol, micro- 
somes and plasma membranes display an alkaline pH 
optimum of 8-9.5 and exhibit an identical response 
to inhibitors such as NaCl and protamine sulfate. The 
highest specific activity is found in plasma membranes. 
Hence, the possibility has been raised that the various 
lipolytic activities represent the plasma membrane 
enzyme that is partially released during homogeniza- 
tion and fractionation [6,7]. 
2. Liver triacylglycerol lipases 
Iipolytic activity in rat liver homogenates was first 
demonstrated by Vavrinkova and Mosinger [2] and 
subsequently has been identified in lysosomal, micro- 
somal, cytosolic and plasma membrane cell fractions 
[3-71. The lipase of lysosomal origin has a pH opti- 
mum of 4-5 and has been partially purified from rat 
[8] and human liver [9]. It requires acidic phospho- 
lipids for optimal activity, and is capable of hydro- 
lysing triacylglycerols, diacylglycerols and cholesterol 
esters. Rat liver lysosomes also contain phospholipase 
C activity producing diacylglycerols from a variety of 
Intravenous injection of heparin in the intact rat 
or perfusion of the isolated liver with heparin results 
in the immediate release of an alkaline lipase from the 
liver [6,12,13]. Tissue fractionation studies have 
shown that the heparin-releasable nzyme is associated 
with the plasma membrane fraction of rat liver homog- 
enates [6,14]. In rat [15,16] and chicken [17] liver, 
the enzyme is synthesized and secreted by the paren- 
chymal cells and subsequently bound to high-affinity 
binding sites on the non-parenchymal (endothelial) 
cells [18,19]. Recent experiments have shown that 
there is only one alkaline lipase in rat liver [ 201. Taken 
together, the foregoing observations suggest hat the 
liver contains only two triacylglycerol lipases: one 
intracellular enzyme with acidic pH optimum and 
located in the lysosomes and one heparin-releasable 
enzyme with alkaline pH optimum and mainly associ- 
ated with the exterior face of the plasma membranes 
of non-parenchymal cells [ 2 11. The heparin-releasable 
lipase is presently thought to play a role in the uptake 
of cholesterol from high-density lipoproteins [21,22]. 
The lysosomal system is certainly involved in the deg- 
radation of lipids taken up by receptor-mediated 
hblished by Elsevier Biomedical Press 
00145793/82/0000-0000/$02.75 0 1982 Federation of European Biochemical Societies 159 
Volume 140, number 2 FEBS LETTERS April 1982 
endocytosis (review [23]). Evidence supporting the 
hypothesis that the lysosomal lipase is also responsible 
for hepatic lipolysis is presented below. 
3. Lysosomal triacylglycerol lipase and hepatic 
lipolysis 
The first suggestion that lysosomes and lysosomal 
lipase might be involved in hepatic lipolysis was raised 
on the basis of the following observations [24]: 
(1) In isolated hepatocytes, several hypoglycemic 
sulfonylureas appeared to exhibit an antilipolytic 
effect, They inhibited ketone body production 
from endogenous fatty acid sources without 
affecting ketogenesis from exogenously added 
labelled oleate. 
(2) In liver homogenates, these drugs inhibited the 
acid lipase without affecting alkaline lipase activ- 
ity. 
Another important observation was that the hepa- 
rin-releasable hepatic lipase was lost during preparation 
of hepatocytes by perfusion in the presence of colla- 
genase [25]. Freshly prepared hepatocytes thus 
appeared to be a well-suited model for the study of 
intracellular lipases and their role in the breakdown 
of endogenous triacylglycerols. Furthermore, while 
the whole liver contains parenchymal and non-paren- 
chymal cells, isolated hepatocytes consist of a nearly 
homogenous population of parenchymal cells. 
Although the relative volume of the non-parenchymal 
cells is -8%, they may contain as much as 40% of the 
liver’s total acid lipase activity. The lipase of non- 
parenchymal cells may be exclusively involved in the 
hydrolysis of triacylglycerols taken up as constituents 
of lipoproteins [26]. 
When isolated hepatocytes were homogenized and 
their lipase activity was measured, it was observed 
that the pH dependence of triacylglycerol lipase dis- 
played one peak of activity with a maximum at 
pH 4.4. An identical pH profile was found in subcel- 
lular fractions several-fold enriched in lysosomes. The 
subcellular distribution of the acidic lipase activity 
was found to follow exactly the distribution of the 
lysosomal marker enzyme acid phosphatase [271. 
Negligible activity was observed in the neutral to alka- 
line pH range. These results indicated that the only 
intracellular lipase of hepatocytes is the lysosomal 
enzyme. This has been confirmed in cultured rat [28] 
and chicken [ 171 hepatocytes and strongly suggests 
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that the lysosomal lipase is responsible for hepatic 
lipolysis. 
Lipolysis in intact hepatocytes cannot be measured 
directly since liberated fatty acids are possibly 
re-esterified and/or oxidized [29]. Endogenous keto- 
genesis, that is the production of ketone bodies from 
endogenous sources in the absence of added free fatty 
acids has been tacitly accepted as a valid index of net 
hepatic lipolysis. In [27] we presented evidence that, 
in hepatocytes from starved rats, endogenous ketones 
are indeed mainly derived from the breakdown of tri- 
acylglycerol. (t)-Octanoylcamitine, an inhibitor of 
the carnitine palmitoyltransferase reaction, very effec- 
tively inhibited endogenous ketogenesis in hepato- 
cytes isolated from 24 h fasted donor rats [27], indi- 
cating that the ketones originated from the oxidation 
of endogenously produced fatty acids. When the hapa- 
tocytes were preincubated with radioactive [ 14C] oleate 
in order tolabel their lipids and subsequently incubated 
in the absence of [ 14C] oleate, the amount of radioac- 
tivity disappearing from the hepatocyte triacylglycer- 
01s was identical with the amount of radioactivity 
found in CO2 plus acid-soluble oxidation products, 
showing that endogenous fatty acid oxidation is a 
reliable index for triacylglycerol breakdown [27]. 
The rate of endogenous ketogenesis was found to 
be identical in isolated hepatocytes and in the per- 
fused rat liver whether or not it had been pretreated 
with heparin [27], supporting the idea that the extra- 
cellular heparin-releasable lipase of the liver does not 
participate in hepatic lipolysis. 
Lysosomotropic compounds [30] such as chloro- 
quine, methylamine and ammonium chloride are 
known to accumulate in lysosomes and to alter several 
lysosomal functions, either by direct inhibition of 
lysosomal enzymes or more likely, through an eleva- 
tion of the intralysosomal pH [3 l-331. In hepato- 
cytes from starved rats these lysosomotropic com- 
pounds inhibited endogenous ketogenesis, without 
affecting ketogenesis from exogenously added oleate, 
as well as the disappearance of label from triacylglyc- 
erols prelabelled with [ 14C]oleate [27]. In the pres- 
ence of different chloroquine concentrations the dis- 
appearance of 14C activity ro p f m relabelled triacyl- 
glycerols was proportional to the formation of label- 
led acid-soluble products [29]. These results fully sup- 
port the idea that the lysosomal lipase is responsible 
for the breakdown of hepatic triacylglycerols. This 
also implies that prior to hydrolysis the triacylglycer- 
01s are taken up in the lysosomes, most probably by 
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autophagocytosis. 
In the same experiments [27], there was a striking 
parallelism between inhibition of both endogenous 
ketogenesis and proteolysis. Since there is good evi- 
dence (review [34]) that endogenous proteolysis in 
perfused liver or isolated hepatocytes is a lysosomal 
process, these results again suggest hat lysosomes are 
involved in hepatic lipolysis. 
In contrast to hepatocytes from starved rats, hepa- 
tocytes prepared from meal-fed donor rats, incubated 
for 1 h with [‘4C]oleate [35] or 3H20 [36], and fur- 
ther incubated in a radioisotope-free buffer did not 
loose significant amounts of label from triacylglycer- 
01s during the second hour of incubation. This shows 
that net hydrolysis of prelabelled triacylglycerols 
does not occur in these cells. Absence of radioactivity 
in acid-soluble oxidation products from hepatocytes 
preincubated with [ 14C]oleate further substantiates 
this observation [35]. Lund et al. [37] have shown 
with hepatocytes prepared from ad libitum-fed rats 
that only negligible amounts of [3H]glycerol (pre- 
incorporated into triacylglycerols) disappear from 
these glycerolipids upon further incubation of the 
cells. In agreement with these studies with radioiso- 
topes, Wirthensohn et al. [38] demonstrated that 
incubation of hepatocytes in the absence of added 
substrates led to a decrease of the content of triacyl- 
glycerols in the celI suspension, if the hepatocyteshad 
been prepared from starved rats. In hepatocytes from 
fed rats this decrease was much smaller and in cells 
from carbohydrate-refed rats net lipolysis was absent 
[38]. It can be concluded that net lipolysis is minimal 
in the fed state. Whether this is due to a decrease in 
lipolytic activity per se or to an active reesterifica- 
tion and/or de novo synthesis of fatty acids cannot be 
concluded from the above experiments. 
A morphological correlate of the association 
between lipids and lysosomes, i.e., the lipolysosome, 
has been described in the liver of cholesterol-fed ham- 
sters [39], in parenchymal cells of normal rat liver 
[40] and in livers of patients with various degrees of 
fatty infiltration [41]. Finally, deficiency of lysoso- 
mal lipase in patients suffering from Wolman’s disease, 
is responsible for a progressive intralysosomal accumu- 
lation of triacylglycerols [42]. 
4. Short-term control of hepatic lipolysis by hxadin 
and glucagon 
Liver slices from starved donor rats show a gluca- 
gon- and CAMP-mediated increase in the output of 
fatty acids [43]. Since both glucagon and CAMP 
increase acyl-CoA levels in liver slices [43] and hepa- 
tocytes [44,45], and since both compounds are 
known to inhibit de novo hepatic fatty acid synthesis 
[ 11, the free fatty acids recovered in the incubation 
medium of the liver slices must have been derived 
from endogenous sources, most likely triacylglycerols. 
Bewsher and Ashmore [46] have demonstrated that 
rat liver homogenates prepared 30 min after the 
injection of glucagon into the intact animal display 
increased rates of fatty acid production from endoge- 
nous sources as compared to liver homogenates from 
rats injected with saline. Furthermore, the fall in tri- 
acylglycerol content was greater in the homogenates 
from glucagon-treated rats [46]. Injection of glucagon 
into starved rats drastically, and rapidly, lowers the 
proportion of triacylglycerols in total hepatic lipids 
[46]. This points to selective hydrolysis of triacylglyc- 
erols. It seems that glucagon activates net hepatic 
lipolysis. Insulin has been shown to reduce the steady- 
state concentration of free fatty acids in the perfusate 
of livers perfused without substrate [47]. However, 
this observation cannot be unequivocally interpreted 
as suggesting an inhibition of lipolysis, since insulin 
stimulates hepatic fatty acid incorporation into tri- 
acylglycerols [48,49]. 
Isolated hepatocytes are a better experimental 
model to study hepatic lipolysis than the intact animal 
or liver slices since in the former system extracellular 
lipolysis will not interfere [25]. Glucagon activates 
(within 1 h after its addition) the formation of r4C- 
labelled acid-soluble oxidation products in hepato- 
cytes prepared from starved rats preincubated with 
[‘4C]oleate [35]. Insulin, on the other hand, inhibits 
the appearance of 14C in acid-soluble products [35]. 
In this experimental system the radioactivity recov- 
ered in the acid-soluble products must be ultimately 
derived from labelled triacylglycerols since (in the 
presence and absence of hormones) the amount of 
labelled free fatty acids in the total incubation does 
not change [35]. The same effects of insulin and glu- 
cagon were demonstrated in a similar approach using 
the perfused rat liver [ 501. The effect of glucagon on 
the production of labelled ketone bodies from pre- 
labelled liver cells is in line with its well-known stimu- 
latory action on the chemically measured endogenous 
ketogenesis [ 5 I-541. 
161 
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5. Mechanisms underlying hormonal control of 
hepatic lipolysis 
Several possible mechanisms may underly hor- 
monal control of hepatic lipolysis. Net lipolysis may 
be indirectly controlled by fatty acid oxidation 
which is under hormonal control. In isolated hepato- 
cytes glucagon stimulates and insulin inhibits the oxi- 
dation of fatty acids, both hormones being effective 
within 1 h after their addition [35]. An increased rate 
of fatty acid oxidation might lower the intracellular 
acyl-CoA and fatty acid levels resulting in an increased 
rate of lipolysis. Inhibition of fatty acid oxidation 
might depress lipolysis by increasing the fatty acid 
and acyl-CoA levels. No experimental evidence for 
such feedback regulation of lipolysis has been 
obtained. Since changes in the rates of fatty acid oxi- 
dation and esteritication are reciprocally related, it is 
likely that fatty acid oxidation at least partly controls 
net hepatic lipolysis by altering the rate of fatty acid 
esterifrcation or reesterification. A possible direct 
inhibition (glucagon) [37,45,49] or stimulation (insu- 
lin) of esterification [49] and re-esterification will 
also influence net hepatic lipolysis. 
Yet another possibility is that lipolysis per se is 
under direct hormonal control. This would imply that 
hepatic triacylglycerol lipase is under endocrine con- 
trol, a view that has often been put forward. In anal- 
ogy to the hormone-sensitive lipase in adipose tissue, 
it has been suggested on the basis of indirect evidence, 
that the liver contains a CAMP-sensitive triacylglycerol 
lipase [43,46,48,54-561. The adipose tissue lipase 
exists in two interconvertible forms, one is phospho- 
rylated and catalytically active, the other one is 
dephosphorylated and inactive [57]. In several abora- 
tories evidence has been obtained that glucagon rapidly 
activates hepatic lipase activity. Bewsher and Ashmore 
[46] observed an increased production of free fatty 
acid from endogenous sources in bicarbonate-buffered 
(PH 7.4) liver homogenates prepared from rats 
injected with glucagon 30 min prior to sacrifice. Like- 
wise, Vavrinkova and Mosinger [58] demonstrated that 
administration of glucagon to intact rats increased 
free fatty acid formation by liver homogenates from 
either endogenous substrate or added triacylglycerols 
at pH 5.0 and 4.8, respectively. Similar results were 
obtained when liver slices were incubated with gluca- 
gon for 10 min [58]. 
Although several authors [43,46,48,.54-561 have 
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proposed that hepatic lipase activity is regulated 
through phosphorylation-dephosphorylation cycles 
as is the adipose tissue lipase, no direct evidence for 
this proposal has been demonstrated. Debeer et al. 
[27] have shown that incubation of hepatocyte 
homogenates with CAMP, ATP and Mg2+ did not 
affect lipolytic activity. The activity of adipose tissue 
lipase is increased under this condition [ 571. Further- 
more, inclusion of NaF in the homogenization and/or 
the lipase assay mixture in order to inhibit possible 
phosphoprotein phosphatase activities, did not affect 
lipolytic activity [ 271. These results suggest hat hep- 
atic lipase is not regulated by a phosphorylation- 
dephosphorylation mechanism. 
On the other hand, autophagocytosis has been pro- 
posed as the mechanism underlying hepatic lipolysis 
[27]. During autophagocytosis, an organelle or por- 
tions of cytoplasm become surrounded by a mem- 
brane and the resulting autophagosome fuses with a 
lysosome. Glucagon induces the formation of hepatic 
autophagic vacuoles in vivo [59] or in the perfused 
liver [60]. During this process, lysosomes become 
more labile and have an increased mechanical and 
osmotic fragility [59]. Insulin and ammo acids seem 
to inhibit autophagocytosis as well as the coupled 
process of lysosomal proteolysis [61]. 
In agreement with an autophagocytotic process of 
hepatic lipolysis, Debeer et al. [27] could not find 
any indication for an activation by glucagon of triacyl- 
glycerol lipase assayed in homogenized hepatocytes 
in the presence of detergent and with an emulsion of 
radioactive triolein as substrate. Likewise, Guder et al. 
[53] did not find an increase in lysosomal lipase activ- 
ity after perfusion of isolated livers with glucagon 
when the enzyme was assayed under hypotonic con- 
ditions (total lipase activity). However, when assayed 
under isotonic conditions, there was an increase in 
the activities (free activities) of both the acid lipase 
and N-acetylQ-D-glucosaminidase, another lysosomal 
enzyme. This increase in free activity was interpreted 
as the expression of the increased fragility of the lyso- 
somes during active phagocytosis. As mentioned 
before, glucagon pretreatment in vivo increased the 
release of free fatty acids from endogenous sources in 
liver homogenates prepared under isotonic conditions 
[46], In these experiments lipolysis may have taken 
place within intact lysosomes explaining the apparent 
discrepancy between these results and those obtained 
by Guder et al. [53] and Debeer et al. [27]. 
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Fig.1. Nutritional and hormonal control of intrahepatic lipolysis: G, glucagon; 1, insulin; 0, a positive effector; 0, a negative 
effector; TG, triacylglycerols; FFA, free fatty acids; AcCoA, acetyl coenzyme A; VLDL, very low density lipoproteins. 
6. Conclusion 
Our present knowledge of the nutritional and hor- 
monal (insulin and glucagon) control of intrahepatic 
lipolysis is summarized in fig.1. 
In the fed state, the predominance of insulin over 
glucagon in the circulation represses hepatic autophag- 
ocytosis and hence hepatic lysosomal lipolysis. In 
addition, insulin stimulates reesterification of fatty 
acids liberated from hepatic triacylglycerols so that 
net lipolysis is low and the appearance of labelled 
acid-soluble oxidation products from prelabelled tri- 
acylglycerols is barely detectable. 
In the fasted state, the hormonal balance shifts in 
favor of glucagon. This results in a more active auto- 
phagocytosis and lipolysis. In addition the stimula- 
tory effect of glucagon on fatty acid oxidation coun- 
teracts active reesterification so that net lipolysis is 
high. 
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